Selective serotonin reuptake inhibitor 'discontinuation syndrome' or withdrawal

被引：19
作者：
Massabki, Ivana [1 ]
Abi-Jaoude, Elia [2 ,3 ]
机构：
[1] McMaster Univ, Arts & Sci Program, Hamilton, ON, Canada
[2] Univ Toronto, Dept Psychiat, Hosp Sick Children, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, Univ Hlth Network, Toronto, ON, Canada
来源：
BRITISH JOURNAL OF PSYCHIATRY | 2021年 / 218卷 / 03期
关键词：
Antianxiety drugs; antidepressants; drug interactions and side-effects; drugs of dependence disorders; depressive disorders; ANTIDEPRESSANT USE; POPULATION; DIAGNOSIS; TRENDS;
D O I：
10.1192/bjp.2019.269
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Attempts to define selective serotonin reuptake inhibitor (SSRI) withdrawal with the term 'discontinuation syndrome' are not supported by evidence. Acknowledging that SSRI use can result in dependence and withdrawal allows patients to be better informed around decisions related to these drugs, and helps inform strategies for safe tapering as appropriate.
引用
收藏
页码：168 / 171
页数：4
相关论文
共 40 条
[31]  
Royal College of Psychiatrists, 2019, POS STAT ANT DEPR
[32]  
Schatzberg A.F., 1997, The Journal of clinical psychiatry, V58, P3
[33]  
Schatzberg AF, 1997, J CLIN PSYCHIAT, V58, P5
[34]  
Schatzberg AF, 1997, J CLIN PSYCHIAT, V58, P23
[35]  
Shelton RC, 2006, J CLIN PSYCHIAT, V67, P3
[36]   SSRI and SNRI withdrawal symptoms reported on an internet forum [J].
Stockmann, Tom ;
Odegbaro, Dolapo ;
Timimi, Sami ;
Moncrieff, Joanna .
INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2018, 29 (3-4) :175-180
[37]   Withdrawal from paroxetine can be severe, warns FDA [J].
Tonks, A .
BRITISH MEDICAL JOURNAL, 2002, 324 (7332) :260-260
[38]   Patients' preferences in the treatment of depressive disorder in primary care [J].
van Schaik, DJF ;
Klijn, AFJ ;
van Hout, HPJ ;
van Marwijk, HWJ ;
Beekman, ATF ;
de Haan, M ;
van Dyck, R .
GENERAL HOSPITAL PSYCHIATRY, 2004, 26 (03) :184-189
[39]   A review of the management of antidepressant discontinuation symptoms [J].
Wilson, Emma ;
Lader, Malcolm .
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2015, 5 (06) :357-368
[40]  
Young AH, 1997, J CLIN PSYCHIAT, V58, P28
1234